Articles > Journals > Medical journals > Pain Research & Management : The Journal of the Canadian Pain Society articles > May 2008

Article: Dyspareunia in postmenopausal women: A critical review

Article from:
Pain Research & Management : The Journal of the Canadian Pain Society
Article date:
May 1, 2008
Author:
Copyright

A Kao, YM Binik, A Kapuscinski, S Khalifé. Dyspareunia in postmenopausal women: A critical review. Pain Res Manage 2008;13(3):243-254.

BACKGROUND: Dyspareunia, or pain during sexual intercourse, is among the problems most frequently reported by postmenopausal women. Past literature has almost unanimously attributed dyspareunic pain occurring during or after the menopausal transition to declining estrogen levels and vaginal atrophy.

OBJECTIVES: To critically review the literature on the prevalence, risk factors, etiology, clinical presentation and treatment of post-menopausal dyspareunia. The present review also examines the traditional and widely held conceptualization of postmenopausal ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: The effects of hormone replacement therapy on cardiovascular ...
Cardiopulmonary Physical Therapy Journal;  January 1, 1999 ;     700+ words ... ... cardiovascular disease (CVD) in postmenopausal women. Discussion of the various mechanisms ... responsible for the development of CVD in postmenopausal women is included. Such mechanisms include ... therapy, cardiovascular disease, postmenopausal women, hormone replacement therapy ...

Article: Health issues in postmenopausal women who drink.
Alcohol Research & Health;  December 22, 2002 ;     700+ words ... ... these three diseases in postmenopausal women. The authors stress ... potential health effects in postmenopausal women should be interpreted ... and well. being of postmenopausal women through the direct ...

Article: FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) ...
PR Newswire;  September 14, 2007 ;     700+ words ... ... reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS ... breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast ...

Article: Metabolic syndrome in postmenopausal women: higher ...
Climacteric;  October 1, 2007 ;     700+ words ... ... III (NCEP)2 in a total of 3965 postmenopausal women, aged 45-64 years, and observed ... cause of morbidity and mortality in postmenopausal women throughout the world and it has ... dimensions, has about 15 million postmenopausal women and widely diverse regions in terms ...

Article: FDA Advisory Committee Recommends Approval of EVISTA for the ...
PR Newswire;  July 24, 2007 ;     700+ words ... ... provide an important option for postmenopausal women at increased risk for breast cancer ... cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer ...

Article: Raloxifene, soy phytoestrogens and endothelial function in ...
Climacteric;  December 1, 2007 ;     700+ words ... ... RALOXIFENE, SOY, PHYTOESTROGENS, POSTMENOPAUSAL WOMEN ABSTRACT Objective To compare the ... endothelial function in healthy, postmenopausal women. Design Randomized, double-blind ... enhanced endothelial function in postmenopausal women. However, the cohort had relatively ...

Article: ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER ...
AsiaPulse News;  March 24, 2009 ;     700+ words ... ... raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS, Mar 23 ... Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly and ... and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive ...

Article: Novartis Launches Z-FAST: A Study Evaluating Femara(R) and ...
PR Newswire;  December 10, 2002 ;     700+ words ... ... treatment-related bone loss in postmenopausal women with early breast cancer Novartis ... associated with cancer treatment in postmenopausal women with early breast cancer. The Novartis ... benefit from this information -- postmenopausal women receiving aromatase inhibitor therapy ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives